Is medical writing entering a new era?
Panellists:
- Peter Llewellyn, Managing Director, NetworkPharma Ltd
- Annette Keith, Executive Scientific Director, Langland
- Liz Stutz, Product Owner, Medical Writing Services, Digital Intelligence & Operations, Roche
- Eleanor Steele, Specialist Trainer, also known as The MedComms Mentor
NetworkPharma, the global initiative to facilitate networking and dialogue amongst medcomms professionals, convened a panel of experts to discuss the adoption of generative AI and its implications for the future of medical writing.
Originally published by NetworkPharma on 31 January 2024.
No items found.
Thought Leadership
Sep 23, 2024
The silent risk of hypertrophic cardiomyopathy
Ahead of World Heart Day on 29 September, we are shining a light on hypertrophic cardiomyopathy (HCM) and the work by Max’s Foundation, a volunteer-led charity founded by Senior Medical Writer I, Molly Schiller and her family, to support research and education on the condition.
Thought Leadership
Mar 28, 2024
Our ability to combat the spread of fake news in the pharmaceutical industry will shape our future
Account Director in Public Relations at Langland, Alexandra Walton, reflects on a thought-provoking panel at the PRWeek UK PharmaComms Conference, ‘Disinformation and misinformation – how can pharma communicators fight it?’
